Medical tech company CONMED (NYSE:CNMD) reported Q4 CY2025 results , with sales up 7.9% year on year to $373.2 million. On ...

CONMED Corporation CNMD is well poised for growth in the coming quarters, courtesy of its broad product spectrum. The optimism, led by the solid first-quarter 2024 performance and a potential General ...

CONMED Corp. has announced its CONMED Endoscopic Technologies unit has launched six new GI/endoscopy medical devices, according to a news release. The devices were launched at the Digestive Disease ...

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including CONMED (NYSE:CNMD) and its peers. The ...

CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025.

Detailed price information for C O N M E D Corp (CNMD-N) from The Globe and Mail including charting and trades.

Detailed price information for C O N M E D Corp (CNMD-N) from The Globe and Mail including charting and trades.

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The ...

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (CNMD) today announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new Independent Chair of its Board of ...

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Mark Kaye will be joining its Board of Directors effective February 24th, 2025. “My fellow directors and I are ...